Memorial Sloan Kettering Cancer Center4d
Clinicopathologic and Genomic Discoveries in Metastatic Lung Cancer
Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
Healio4d
‘It can save their lives’: Annual lung cancer screening improves cancer detection rate
Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...
Medscape1d
A ‘Fool’s Errand’? Picking a Winner for Treating Early-Stage NSCLC
Emerging data suggest that SBRT may be comparable with surgery for definitive treatment of stage I NSCLC in certain patients. When is one approach preferred and in whom?
HealthDay on MSN8d
Lung Cancer Screening Adherence Rates Decline Annually After Baseline Screening
Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individu ...
Rheumatology Advisor3d
TNF Inhibitor Use in RA With Early-Stage Cancer Does Not Decrease Survival
In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.
Targeted Oncology8h
BNT327 With Chemotherapy Elicits Strong Results in ES-SCLC
BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...
PharmExec2d
Updated Trial Results Support Tagrisso as Standard-of-Care for EGFR-Mutated Lung Cancer
Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung ...
CURE3d
First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...